MedMira Awarded China Patent
Rapid Flow-Through Technology Patents in Three Major Global Markets
"Patents on our core technology in three major global markets are fundamental components of our plan to grow our business through strategic partnerships. While we continue to pursue patent protection for our progressive IP estate in additional markets, we can now fully engage in collaborative relationships to tap opportunities in three of the most lucrative markets of the $40 billion global diagnostics market," said Hermes Chan, President and CEO, MedMira Inc. "These partnerships, taking shape in various forms including licensing, commercialization, and contract manufacturing, will enable both new business and new innovation opportunities for MedMira."
Most read news
Other news from the department research and development
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.